Navigation Links
Drug innovation beats marketing, patents and mergers

In a recent BusinessWeek article profiling the significant rise in valuation of Genentech (NYSE: DNA), the authors point out that it is true product innovation through focused R&D efforts that's currently paying off in terms of investor confidence and resulting market valuation.

While Genentech had revenues of $4.6 bi......

Full article >>> r its two lead cancer drugs as well as other cancer drugs called Tarceva and Rituxan. Additional cancer drugs (such as Omnitarq in Phase II as well as another drug in Phase I) provide the company with one of the best cancer product portfolios.

The message here is that focused and productive R&D churning out innovative new drugs is currently winning the day over M&A, marketing and even sav......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 05/03/05


Related biology technology :

1. Changes to U.S. patent law must nurture our culture of innovation
2. Abbott vs. Thailand has implications for innovation and access
3. Visions: Benson touts embedded innovation
4. UW System must remove barriers to innovation
5. In western Wisconsin, the innovation economy is growing
6. Scott Converse, UW-Madison School of Business, on the innovation mind-set
7. New CEO at TDS on creating a culture of innovation (Part 2)
8. New CEO at TDS on tech innovation and leadership (Part 1)
9. Creativity, innovation extend to municipalities
10. Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesnt nurture it
11. TechnoJungle to highlight learning, innovation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... to utilize LungDirect for pulmonary nodule patient management. In ... nodule, or a spot on the lung, UCHealth looks ... on manual data entry. Stephanie Brown, ... tracking my nodule patients with an Excel spreadsheet, which ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology:
(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
(Date:1/19/2017)... , January 19, 2017 According to a new ... and Forecast, 2014 - 2022," the global biometric sensor market is expected to ... to 2022. In 2015, Asia-Pacific dominated the global market ... private sectors. Continue Reading ... ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):